The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 29th 2024
Rick C. McCoy, RPh, and Marge McCoy, RPh, combine decades of experience working side by side with a dedication to serving their island community.
HIV Transmission Wanes as Patients Progress Through Care Continuum
March 15th 2015More than 90% of HIV transmissions originate from undiagnosed and untreated individuals. On the other hand, those retained in medical care who have achieved viral suppression are 94% less likely to transmit HIV.
Read More
Pharmacist Roles Expanding in Chronic Disease Management
March 14th 2015From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.
Read More
Two East Coast Researchers to Receive $100,000 Potamkin Prize for Alzheimer's Research
March 14th 2015The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital.
Read More
Suicide Prevention Tools Launched by Facebook, SAMHSA
March 13th 2015Loved ones, friends, and health care providers of individuals whom they believe to be at risk of suicide will soon have access to new tools developed by Facebook and SAMHSA that will enable them to better help those in need.
Read More
Controlled-Substance Prescriptions: Watching for "Red Flags"
March 13th 2015The National Association of Boards of Pharmacy in conjunction with various other stakeholder organizations has recently released a consensus document titled "Stakeholders' Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances."
Read More
FDA Approves New Pediatric Treatment for Bipolar Disorder
March 13th 2015The FDA today approved the supplemental new drug application for asenapine (Saphris) as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder for patients aged 10 to 17 years.
Read More